CORR Insights(®): Risk of Post-TKA Acute Myocardial Infarction in Patients With a History of Myocardial Infarction or Coronary Stent.
作者信息
Attarian David E
机构信息
Department of Orthopaedic Surgery, Duke University School of Medicine, 4709 Creekstone Drive, Suite 200, Durham, NC, 27710, USA.
出版信息
Clin Orthop Relat Res. 2016 Feb;474(2):487-8. doi: 10.1007/s11999-015-4642-x. Epub 2015 Nov 23.
Abstract
摘要
相似文献
1
CORR Insights(®): Risk of Post-TKA Acute Myocardial Infarction in Patients With a History of Myocardial Infarction or Coronary Stent.CORR见解(®)：有心肌梗死或冠状动脉支架置入史的患者全膝关节置换术后急性心肌梗死的风险
Clin Orthop Relat Res. 2016 Feb;474(2):487-8. doi: 10.1007/s11999-015-4642-x. Epub 2015 Nov 23.
2
Risk of Post-TKA Acute Myocardial Infarction in Patients With a History of Myocardial Infarction or Coronary Stent.有心肌梗死或冠状动脉支架置入史的患者全膝关节置换术后急性心肌梗死的风险
Clin Orthop Relat Res. 2016 Feb;474(2):479-86. doi: 10.1007/s11999-015-4616-z. Epub 2015 Nov 13.
3
Pyogenic infection of the hip joint as a complication of a femoral artery vascular access for percutaneous coronary intervention.作为经皮冠状动脉介入治疗时股动脉血管穿刺的并发症，髋关节发生化脓性感染。
Ther Adv Cardiovasc Dis. 2018 May;12(5):155-160. doi: 10.1177/1753944718756571. Epub 2018 Feb 18.
4
Response to letter regarding article, "Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations".对关于《三代冠状动脉支架植入术后支架内再狭窄的临床表现及结局》一文的信件的回复
Circ Cardiovasc Interv. 2015 Apr;8(4). doi: 10.1161/CIRCINTERVENTIONS.115.002459.
5
Letter by De Rosa and Indolfi regarding article, "Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations".德罗萨和因多尔菲就文章《三代冠状动脉支架内再狭窄的临床表现及预后》所写的信。
Circ Cardiovasc Interv. 2015 Apr;8(4). doi: 10.1161/CIRCINTERVENTIONS.115.002375.
6
Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.生物可吸收血管支架治疗冠状动脉支架内再狭窄的长期临床结果：意大利多中心经验。
Circ Cardiovasc Interv. 2016 Apr;9(4):e003148. doi: 10.1161/CIRCINTERVENTIONS.115.003148.
7
Stent for Life: how this initiative began?支架为生命：这个倡议是如何开始的？
EuroIntervention. 2012 Aug;8 Suppl P:P8-10. doi: 10.4244/EIJV8SPA3.
8
Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention With Current-Generation Drug-Eluting Stent.当前代药物洗脱支架经皮冠状动脉介入治疗左主干与非左主干分叉病变的治疗策略的预后影响。
Circ Cardiovasc Interv. 2020 Feb;13(2):e008543. doi: 10.1161/CIRCINTERVENTIONS.119.008543. Epub 2020 Feb 7.
9
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry.急性心肌梗死患者应用生物可降解聚合物西罗莫司洗脱支架的 1 年临床结果：ULISSE 注册研究的见解。
Catheter Cardiovasc Interv. 2019 Dec 1;94(7):972-979. doi: 10.1002/ccd.28305. Epub 2019 Apr 29.
10
Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention?大血管直径是否支持在初次经皮冠状动脉介入治疗中使用裸金属支架？
Circ Cardiovasc Interv. 2019 Sep;12(9):e007705. doi: 10.1161/CIRCINTERVENTIONS.118.007705. Epub 2019 Aug 27.
本文引用的文献
1
Preventing Hospital Readmissions and Limiting the Complications Associated With Total Joint Arthroplasty.预防医院再入院并限制全关节置换术相关并发症
Instr Course Lect. 2016;65:199-210.
2
Can the American College of Surgeons Risk Calculator Predict 30-Day Complications After Knee and Hip Arthroplasty?美国外科医师学会风险计算器能否预测膝关节和髋关节置换术后的30天并发症？
J Arthroplasty. 2015 Sep;30(9 Suppl):5-10. doi: 10.1016/j.arth.2015.01.057. Epub 2015 May 27.
3
2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.2014年美国心脏病学会/美国心脏协会非心脏手术患者围手术期心血管评估和管理指南：美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Dec 9;64(22):e77-137. doi: 10.1016/j.jacc.2014.07.944. Epub 2014 Aug 1.
Zotero 插件